Tag: GlaxoSmithKline



First Non-inhaled Treatment for Severe Asthma Shows Promise

GlaxoSmithKline reported positive results from 2 phase-III clinical trials for mepolizumab, a new treatment for severe eosinophilic asthma. If the drug were to receive FDA approval, it would become the first non-inhaled treatment for severe asthma.

Sorry, No Posts Found